343 related articles for article (PubMed ID: 28043717)
1. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
Verma M; Gupta SJ; Chaudhary A; Garg VK
Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Res Rev; 2012 May; 32(3):459-517. PubMed ID: 20814956
[TBL] [Abstract][Full Text] [Related]
3. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
4. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationship (QSAR) and design of novel ligands that demonstrate high potency and target selectivity as protein tyrosine phosphatase 1B (PTP 1B) inhibitors as an effective strategy used to model anti-diabetic agents.
Arthur DE; Ejeh S; Uzairu A
J Recept Signal Transduct Res; 2020 Dec; 40(6):501-520. PubMed ID: 32397858
[TBL] [Abstract][Full Text] [Related]
6. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018).
Verma SK; Yadav YS; Thareja S
Mini Rev Med Chem; 2019; 19(7):591-598. PubMed ID: 30968766
[TBL] [Abstract][Full Text] [Related]
7. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
Popov D
Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
[TBL] [Abstract][Full Text] [Related]
8. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
Prabhakar PK; Sivakumar PM
Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
[TBL] [Abstract][Full Text] [Related]
9. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
[TBL] [Abstract][Full Text] [Related]
10. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
Kasibhatla B; Wos J; Peters KG
Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in protein tyrosine phosphatase 1B inhibitors.
Taylor SD; Hill B
Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
13. An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors.
Bibi S; Sakata K
Curr Comput Aided Drug Des; 2017 Nov; 13(4):319-335. PubMed ID: 28382867
[TBL] [Abstract][Full Text] [Related]
14. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
15. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
Wang C; Wang L; Yang Z
Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
Fukuda S; Ohta T; Sakata S; Morinaga H; Ito M; Nakagawa Y; Tanaka M; Matsushita M
Diabetes Obes Metab; 2010 Apr; 12(4):299-306. PubMed ID: 20380650
[TBL] [Abstract][Full Text] [Related]
17. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
19. Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs.
Genovese M; Nesi I; Caselli A; Paoli P
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443409
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
